MX2019000269A - Preparacion con el microorganismo micoparasito pythium oligandrum viable para el tratamiento de dermafitosis y candidiasis en la piel y membranas mucosas, metodo para determinar la viabilidad de la celula del microorganismo pythium oligandrum y metodo de aplicacion de la preparacion. - Google Patents
Preparacion con el microorganismo micoparasito pythium oligandrum viable para el tratamiento de dermafitosis y candidiasis en la piel y membranas mucosas, metodo para determinar la viabilidad de la celula del microorganismo pythium oligandrum y metodo de aplicacion de la preparacion.Info
- Publication number
- MX2019000269A MX2019000269A MX2019000269A MX2019000269A MX2019000269A MX 2019000269 A MX2019000269 A MX 2019000269A MX 2019000269 A MX2019000269 A MX 2019000269A MX 2019000269 A MX2019000269 A MX 2019000269A MX 2019000269 A MX2019000269 A MX 2019000269A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- pythium oligandrum
- microorganism
- viable
- cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dispersion Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Abstract
Una preparación que contiene el microorganismo micoparásito Pythium oligandrum para el tratamiento de la dermatofitosis y candidiasis en la piel y las membranas mucosas obtenida de una mezcla seca que contiene 0.1 a 99.9% en peso de microorganismo micoparásito Pythium oligandrum y 0.1 a 99.9% en sustancias auxiliares, que contiene al menos un componente de un grupo que comprende absorbentes, tampones, humectantes, desodorantes y aromas. La presente preparación contiene 1 a 10 x 106, con preferencia de 10 a 50, células viables del microorganismo Pythium oligandrum por 1 ml de suspensión acuosa en el sitio de aplicación de la preparación, con lo cual las células viables del microorganismo Pythium oligandrum comprende oosporas latentes, zoosporas enquistadas y micelio cenocítico. Se reivindican diferentes métodos de aplicación para usar la preparación. Modalidades ejemplares muestran la viabilidad de células utilizando pruebas genéticas y pruebas prácticas llevadas a cabo bajo la supervisión de dermatólogos, estomatólogos y veterinarios.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CZ2016403 | 2016-07-01 | ||
| CZ2016-417A CZ307642B6 (cs) | 2016-07-08 | 2016-07-08 | Přípravek s mykoparazitickým mikroorganizmem Pythium oligandrum pro užití při léčbě dermatofytos a kvasinkových infekcí na kůži a sliznicích |
| PCT/CZ2016/000095 WO2018001392A1 (en) | 2016-07-01 | 2016-08-22 | Preparation with the viable mycoparasitic microorganism pythium oligandrum for the treatment of dermaphytoses and yeast infections on the skin and mucous membranes, method of determining the cell's viability of the microorganism pythium oligandrum and method of applying the preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2019000269A true MX2019000269A (es) | 2019-05-27 |
Family
ID=66847908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019000269A MX2019000269A (es) | 2016-07-01 | 2016-08-22 | Preparacion con el microorganismo micoparasito pythium oligandrum viable para el tratamiento de dermafitosis y candidiasis en la piel y membranas mucosas, metodo para determinar la viabilidad de la celula del microorganismo pythium oligandrum y metodo de aplicacion de la preparacion. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11331356B2 (es) |
| EP (1) | EP3478302B1 (es) |
| JP (2) | JP6667501B2 (es) |
| KR (1) | KR20190064563A (es) |
| CN (1) | CN110225759B (es) |
| BR (1) | BR112018077463B1 (es) |
| CA (1) | CA3029484A1 (es) |
| ES (1) | ES2957887T3 (es) |
| MX (1) | MX2019000269A (es) |
| WO (1) | WO2018001392A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018068774A2 (en) * | 2016-10-14 | 2018-04-19 | Biopreparáty, Spol. S R.O | Biological antifugal liquid preparation with microorganism pythium oligandrum and method of production |
| CZ309743B6 (cs) * | 2021-12-14 | 2023-09-06 | Ústav chemických procesů AV ČR, v.v.i. | Způsob výroby extraktu z Pythium oligandrum pro potlačení růstu buněk kožního melanomu, extrakt připravitelný tímto způsobem a jeho použití |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS213659B1 (en) * | 1978-07-05 | 1982-04-09 | Dasa Vesely | Means for protection the sugar beet against the scarlet fever on the base of cospor mykroparazita pythium oligandrum |
| US5961971A (en) * | 1996-10-17 | 1999-10-05 | University Of Florida | Biocontrol of fungal soilborne pathogens by Pythium oligandrum |
| CZ9883U1 (cs) | 1999-11-18 | 2000-04-14 | Dasa Doc Ing Drsc Vesely | Prostředek na ochranu pokožky využívající houbu Pythium oligandrum |
| CZ302297B6 (cs) | 2009-11-04 | 2011-02-09 | Bio Agens Research And Development - Bard, S.R.O. | Protiplísnová smes s houbovým organismem Pythium oligandrum |
| WO2012076563A1 (en) * | 2010-12-08 | 2012-06-14 | Basf Se | Fungicidal mixtures |
| BR112017006671B1 (pt) * | 2014-10-02 | 2022-03-15 | Bayer Cropscience Biologics Gmbh | Composição líquida compreendendo um agente de controle biológico, seu uso e seu método de produção, e método para controle de fungos fitopatogênicos, insetos, aranhas, moluscos, ervas, roedores e/ou nematódos em uma planta, ou para aumentar o crescimento de uma planta ou a saúde das raízes |
| CZ201523A3 (cs) * | 2015-01-16 | 2016-07-27 | Bio Agens Research And Development - Bard, S.R.O. | Duální mikrobiální preparát pro dlouhodobé potlačení nebo prevenci symptomů oportunních mikrobiálních infekcí |
| CZ28816U1 (cs) * | 2015-01-16 | 2015-11-16 | Bio Agens Research And Development - Bard, S.R.O. | Duální mikrobiální preparát pro dloubodobé potlačení nebo prevenci symptomů oportunních mikrobiálních infekcí |
| CN105274241A (zh) * | 2015-11-21 | 2016-01-27 | 云南省烟草公司大理州公司 | 一种烟草根黑腐病菌分子检测引物及其快速检测方法 |
-
2016
- 2016-08-22 ES ES16763432T patent/ES2957887T3/es active Active
- 2016-08-22 BR BR112018077463-4A patent/BR112018077463B1/pt not_active IP Right Cessation
- 2016-08-22 CA CA3029484A patent/CA3029484A1/en not_active Abandoned
- 2016-08-22 MX MX2019000269A patent/MX2019000269A/es unknown
- 2016-08-22 CN CN201680088849.6A patent/CN110225759B/zh active Active
- 2016-08-22 KR KR1020197003237A patent/KR20190064563A/ko unknown
- 2016-08-22 WO PCT/CZ2016/000095 patent/WO2018001392A1/en unknown
- 2016-08-22 EP EP16763432.8A patent/EP3478302B1/en active Active
- 2016-08-22 JP JP2017504824A patent/JP6667501B2/ja active Active
- 2016-08-22 US US16/314,108 patent/US11331356B2/en active Active
-
2019
- 2019-10-04 JP JP2019184069A patent/JP2020073475A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018528154A (ja) | 2018-09-27 |
| CA3029484A1 (en) | 2018-01-04 |
| EP3478302A1 (en) | 2019-05-08 |
| BR112018077463A2 (pt) | 2019-04-02 |
| JP6667501B2 (ja) | 2020-03-18 |
| WO2018001392A1 (en) | 2018-01-04 |
| CN110225759A (zh) | 2019-09-10 |
| EP3478302B1 (en) | 2023-07-05 |
| US11331356B2 (en) | 2022-05-17 |
| BR112018077463B1 (pt) | 2021-12-07 |
| CN110225759B (zh) | 2023-09-29 |
| JP2020073475A (ja) | 2020-05-14 |
| ES2957887T3 (es) | 2024-01-29 |
| US20200085893A1 (en) | 2020-03-19 |
| KR20190064563A (ko) | 2019-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP22000189A (es) | Composición que comprende un agente de control biológico y un fungicida | |
| BR112017014060A2 (pt) | composições de bacillus licheniformis rti184 e métodos de uso para beneficiar o crescimento de plantas | |
| AR106800A1 (es) | Composiciones que comprenden cepas bacterianas | |
| CL2016001235A1 (es) | Cepa bacteriana aislada del genero burkholderia y metabolitos plaguicidas derivados-formulaciones y usos (divisional solicitud 467-2014). | |
| CR20150292A (es) | Composición que comprende agentes de control biológico | |
| AR091196A1 (es) | Composicion que comprende un agente de control biologico y un fungicida | |
| AR091199A1 (es) | Composicion que comprende un agente de control biologico y un fungicida | |
| CY1123343T1 (el) | Παραγωγη μιας τραπεζας μεσεγχυματικων στρωματικων κυτταρων απο τα ομαδοποιημενα μονοπυρηνα κυτταρα πολλαπλων δοτων μυελου των οστων | |
| CL2012003401A1 (es) | Compuestos derivados de carbamato de hexafluoroisopropilo, inhibidores de la enzima monoacil glicerol lipasa (mgl); proceso de preparacion; medicamento; compuestos intermediarios; composicion farmaceutica; y su uso para tratar o prevenir dolores agudos o cronicos, vertigos, dislipidemias y epilepsia, entre otras enfermedades. | |
| BR112017011067A2 (pt) | cepas e métodos para a partição de energia em ruminantes | |
| ECSP14029210A (es) | Composición que comprende un agente de control biológico y un fungicida | |
| ECSP14029182A (es) | Composición que comprende un agente de control biológico y un fungicida | |
| BR112013011263A2 (pt) | "composição nematicida, e método para controlar nematódeos" | |
| ECSP14029225A (es) | Composición que comprende un agente de control biológico y un fungicida | |
| BR112012013720A2 (pt) | uso cosmético de pelo menos um microorganismo probiótico, especialmente do gênero lactobacillus sp.e processo cosmético. | |
| CN103340909B8 (zh) | 一种灵芝孢子粉的生物破壁方法 | |
| EA201490995A1 (ru) | Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток | |
| MY186172A (en) | Endogenous dnase activity to reduce dna content | |
| MX2019000269A (es) | Preparacion con el microorganismo micoparasito pythium oligandrum viable para el tratamiento de dermafitosis y candidiasis en la piel y membranas mucosas, metodo para determinar la viabilidad de la celula del microorganismo pythium oligandrum y metodo de aplicacion de la preparacion. | |
| EP4316497A3 (en) | Mesenchymal stem cells as vaccine adjuvants and methods for using the same | |
| ECSP15022084A (es) | Composición que comprende un agente de control biológico y un fungicida | |
| WO2019028422A9 (en) | METHODS OF ACTIVATION OF IMMUNE CELLS | |
| WO2018085516A3 (en) | Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases | |
| SG11201810188VA (en) | Amelioration and treatment of perinatal brain damage with pluripotent stem cells | |
| PE20221731A1 (es) | NUEVO USO DE FORMULACION INMUNOGENICA BCG QUE EXPRESA UNA PROTEINA DE VIRUS RESPIRATORIO SINCICIAL CONTRA hMPV |